Skip to main navigation

Skip to content

Search for:

About
Technology
Pipeline
Products
- XIPERE®
Investors

Investor Menu

IR Overview
News
Events and Presentations
Governance
SEC Filings
Financial Info
Resources

Quarterly Summary

Show all

2022

Q4

Clearside Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Clearside Biomedical Q4 2022 Financial Results and Corporate Update Call
Form 10-K

Q3

Clearside Biomedical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
Clearside Biomedical Q3 2022 Financial Results and OASIS Clinical Trial Data Call
OASIS Phase 1/2a Clinical Trial Results Presentation 3.7 MB
Form 10-Q

Q2

Clearside Biomedical Announces Second Quarter 2022 Financial Results and Provides Corporate Update
Clearside Biomedical Q2 2022 Financial Results and Corporate Update Call
Form 10-Q

Q1

Clearside Biomedical Announces First Quarter 2022 Financial Results and Provides Corporate Update
Clearside Biomedical Q1 2022 Financial Results and Corporate Update Call
Form 10-Q

2021

Q4

Clearside Biomedical Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Form 10-K

Q3

Clearside Biomedical Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Form 10-Q

Q2

Clearside Biomedical Announces Second Quarter 2021 Financial Results and Provides Corporate Update
CLS-AX OASIS Cohort 1 Clinical Data Summary Slides 741.4 KB
Form 10-Q

Q1

Clearside Biomedical Announces First Quarter 2021 Financial Results and Provides Corporate Update
Form 10-Q

2020

Q4

Clearside Biomedical Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Form 10-K

Q3

Clearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate Update
Form 10-Q

Q2

Clearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update
Form 10-Q

Q1

Clearside Biomedical Announces First Quarter 2020 Financial Results
Form 10-Q

2019

Q4

Clearside Biomedical Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Form 10-K

Q3

Clearside Biomedical Announces Third Quarter 2019 Financial Results and Provides Corporate Update
Form 10-Q

Q2

Clearside Biomedical Announces Second Quarter 2019 Financial Results and Provides Corporate Update
Form 10-Q

Q1

Clearside Biomedical Announces First Quarter 2019 Financial Results and Provides Corporate Update
Form 10-Q

2018

Q4

Clearside Biomedical Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Form 10-K

Q3

Clearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update
Form 10-Q

Q2

Clearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate Update
Form 10-Q

Q1

Clearside Biomedical Announces First Quarter 2018 Financial Results and Provides Corporate Update
Form 10-Q

2017

Q4

Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update
Form 10-K

Q3

Clearside Biomedical, Inc. Announces Third Quarter 2017 Financial Results and Provides Corporate Update
Form 10-Q

Q2

Clearside Biomedical, Inc. Announces Second Quarter 2017 Financial Results and Provides Corporate Update
Form 10-Q

Q1

Clearside Biomedical, Inc. Announces First Quarter 2017 Financial Results and Provides Corporate Update
Form 10-Q

Email Alerts
Print Page
RSS Feeds
IR Contact

Request Email Alerts

(678) 270-3631
info@clearsidebio.com
CONTACT US

ABOUT US
MANAGEMENT
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
PRIVACY POLICY

SCIENCE
SUPRACHOROIDAL SPACE
SCS MICROINJECTOR®
PUBLICATIONS & PRESENTATIONS
Intellectual Property

PRODUCTS
XIPERE™

PIPELINE
CLS-AX
INTEGRIN INHIBITOR
GENE THERAPY
COLLABORATIONS

INVESTORS
IR OVERVIEW
NEWS
EVENTS & PRESENTATIONS
GOVERNANCE
SEC FILINGS
FINANCIAL INFO
RESOURCES

Go to Top